The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
acyclovir
Acyclovir · ACYCLOVIR SODIUM 50 mg/mL · Injection, Solution · Intravenous · Zydus Pharmaceuticals (USA) Inc.
NDC 68382-0049-10 · 10 VIAL, SINGLE-USE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-USE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $18.39 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA206535
- TE code
- AP
- Approval date
- Aug 31, 2018
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class I · TerminatedFeb 18, 2021Zydus Pharmaceuticals (USA) Inc — Crystallization: customer complaints for crystallization in finished product.
- Class I · TerminatedFeb 18, 2021Zydus Pharmaceuticals (USA) Inc — Crystallization: customer complaints for crystallization in finished product.
Manufacturers of Acyclovir (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fresenius Kabi USA, LLC | ACYCLOVIR SODIUM 50 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Zydus Pharmaceuticals (USA) Inc. | ACYCLOVIR SODIUM 50 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Slate Run Pharmaceuticals, LLC | ACYCLOVIR SODIUM 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | ACYCLOVIR SODIUM 50 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "acyclovir — NDC 68382-0049-10," retrieved September 3, 2026, https://drugdashboards.com/drug/68382004910.
Free to cite with attribution — see how the data is put together.